[Federal Register Volume 84, Number 67 (Monday, April 8, 2019)]
[Notices]
[Pages 13926-13927]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-06813]



[[Page 13926]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-19-19AEG; Docket No. CDC-2019-0025]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
Federal agencies the opportunity to comment on a proposed and/or 
continuing information collection, as required by the Paperwork 
Reduction Act of 1995. This notice invites comment on a proposed 
information collection project titled Verona Integron-Encoded Metallo-
[beta]-Lactamase (VIM)-Producing Carbapenem-Resistant Pseudomonas 
aeruginosa Infections Associated with Invasive Medical Procedures in 
Tijuana, Mexico. This project is being developed to identify infections 
among individuals in the U.S. who had surgery at Facility 1 in Tijuana, 
Mexico in order to prevent the spread of resistance in the U.S.

DATES: CDC must receive written comments on or before June 7, 2019.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2019-
0025 by any of the following methods:
     Federal eRulemaking Portal: Regulations.gov. Follow the 
instructions for submitting comments.
     Mail: Jeffrey M. Zirger, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS-D74, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to Regulations.gov.

    Please note:  Submit all comments through the Federal 
eRulemaking portal (regulations.gov) or by U.S. mail to the address 
listed above.


FOR FURTHER INFORMATION: To request more information on the proposed 
project or to obtain a copy of the information collection plan and 
instruments, contact Jeffrey M. Zirger, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: 
[email protected].

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
Federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to the OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected; and
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses.
    5. Assess information collection costs.

Proposed Project

    Verona Integron-Encoded Metallo-[beta]-Lactamase (VIM)-Producing 
Carbapenem-Resistant Pseudomonas aeruginosa Infections Associated with 
Invasive Medical Procedures in Tijuana, Mexico--New--National Center 
for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for 
Disease Control and Prevention (CDC).

Background and Brief Description

    CDC is investigating an outbreak of highly resistant Pseudomonas 
aeruginosa infections associated with bariatric surgery at a hospital 
in Tijuana, Mexico. Approximately 750 Americans from 45 states have had 
surgery at this facility since August 1, 2018. Among these individuals, 
approximately 200 had surgery since January 1, 2019, and are still at 
risk for developing infection and/or having infections that are still 
being treated in the U.S. healthcare system. CDC recently received the 
contact information for these exposed individuals to enable public 
health response. To help prevent spread of this resistant organism in 
U.S. hospitals, and to ensure that individuals who develop infection 
get prompt and appropriate treatment, a public health response was 
initiated to contact individuals exposed to Facility 1 in order to 
assess whether they developed infections and whether they have been 
hospitalized since their surgery in Mexico.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden
      Type of respondents           Form name        Number of     responses per   per response    Total burden
                                                    respondents     respondent      (in hours)      (in hours)
----------------------------------------------------------------------------------------------------------------
Individuals exposed for         Verona Integron-             197               1           20/60              66
 Facility 1 since January 1,     Encoded Metallo-
 2019.                           [beta]-
                                 Lactamase (VIM)-
                                 Producing
                                 Carbapenem-
                                 Resistant
                                 Pseudomonas
                                 aeruginosa
                                 Infections
                                 Associated with
                                 Invasive
                                 Medical
                                 Procedures in
                                 Tijuana,
                                 Mexico: Survey.
                                                 ---------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............              66
----------------------------------------------------------------------------------------------------------------



[[Page 13927]]

Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2019-06813 Filed 4-5-19; 8:45 am]
 BILLING CODE 4163-18-P